Acute morphological sequelae of photodynamic therapy with 5-aminolevulinic acid in the C6 spheroid model

ObjectiveAminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) may represent a treatment option for malignant brain tumors. We used a three-dimensional cell culture system, the C6 glioma spheroid model, to study acute effects of PDT and how they might be influenced by treatment conditions.MethodsSpheroids were incubated for 4 h in 100 μg/ml ALA in 5% CO2 in room air or 95% O2 with subsequent irradiation using a diode laser (λ = 635 nm, 40 mW/cm2, total fluence 25 J/cm2). Control groups were “laser only”, “ALA only”, and “no drug no light”. Annexin V-FITC, a marker used for detection of apoptosis, propidium iodide (PI), a marker for necrotic cells and H 33342, a chromatin stain, were used for morphological characterization of PDT effects by confocal laser scanning and fluorescence microscopy. Hematoxylin–eosin staining and TdT-FragEL (TUNEL) assay were used on cryosections. Growth kinetics were followed for 8 days after PDT.ResultsPDT after incubation in 5% CO2 provided incomplete cell death and growth delay in spheroids of >350 μm diameter. However, complete cell death and growth arrest occurred in smaller spheroids (<350 μm). Incubation in 95% O2 with subsequent PDT resulted in complete cell death and growth arrest regardless of spheroid size. In incompletely damaged spheroids viable cells were restricted to spheroid centers. The rate of cell death in all control groups was negligible. Cell death was accompanied by annexin/PI costaining, but there was also evidence for annexin V-FITC staining without PI uptake.ConclusionsPDT of experimental glioma results in rapid and significant cell death that could be verified as acute necrosis immediately after irradiation. This effect depended on O2 concentration and spheroid size.

[1]  H Stepp,et al.  Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. , 1998, Neurosurgery.

[2]  Marcel Leist,et al.  Four deaths and a funeral: from caspases to alternative mechanisms , 2001, Nature Reviews Molecular Cell Biology.

[3]  A H Kaye,et al.  Photodynamic therapy of brain tumors. , 1995, Journal of clinical laser medicine & surgery.

[4]  Henry Hirschberg,et al.  Effects of Combined Photodynamic Therapy and Ionizing Radiationon Human Glioma Spheroids¶ , 2002, Photochemistry and photobiology.

[5]  Henry Hirschberg,et al.  5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review). , 2002, International journal of oncology.

[6]  I. Whittle,et al.  The development of necrosis and apoptosis in glioma: experimental findings using spheroid culture systems* , 2001, Neuropathology and applied neurobiology.

[7]  Tobias Kiesslich,et al.  Characterization of the cell death modes and the associated changes in cellular energy supply in response to AlPcS_4-PDT , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[8]  Bruce J. Tromberg,et al.  Enhanced cytotoxic effects of 5-aminolevulinic acid-mediated photodynamic therapy by concurrent hyperthermia in glioma spheroids , 2004, Journal of Neuro-Oncology.

[9]  D. Kessel,et al.  Side effects and photosensitization of human tissues after aminolevulinic acid. , 1997, The Journal of surgical research.

[10]  A. Brandes,et al.  State-of-the-art treatment of high-grade brain tumors. , 2003, Seminars in oncology.

[11]  Nancy L Oleinick,et al.  The role of apoptosis in response to photodynamic therapy: what, where, why, and how , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[12]  Bernhard Olzowy,et al.  Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. , 2002, Journal of neurosurgery.

[13]  M. Kao,et al.  Comparative study on the ALA photodynamic effects of human glioma and meningioma cells , 1999, Lasers in surgery and medicine.

[14]  M G Nichols,et al.  Oxygen diffusion and reaction kinetics in the photodynamic therapy of multicell tumour spheroids. , 1994, Physics in medicine and biology.

[15]  B. Wilson,et al.  Photodynamic therapy for recurrent supratentorial gliomas. , 1995, Seminars in surgical oncology.

[16]  W. Stummer,et al.  Photodynamic therapy within edematous brain tissue: considerations on sensitizer dose and time point of laser irradiation. , 1996, Journal of photochemistry and photobiology. B, Biology.

[17]  C. Reutelingsperger,et al.  Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. , 1998, Cytometry.

[18]  V. Wallace,et al.  Photodynamic Therapy of Human Glioma Spheroids Using 5-Aminolevulinic Acid¶ , 2000, Photochemistry and photobiology.

[19]  M G Nichols,et al.  Fluence rate effects in photodynamic therapy of multicell tumor spheroids. , 1993, Cancer research.

[20]  M G Nichols,et al.  The Mechanism of Photofrin Photobleaching and Its Consequences for Photodynamic Dosimetry , 1997, Photochemistry and photobiology.

[21]  Bruce J. Tromberg,et al.  Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids , 2003, Journal of Neuro-Oncology.

[22]  W. Rachinger,et al.  Oedema formation in experimental photo-irradiation therapy of brain tumours using 5-ALA , 2004, Acta Neurochirurgica.

[23]  A Knappe,et al.  [Computer-controlled laser irradiation unit for studies of light-induced processes in cell cultures]. , 1995, Biomedizinische Technik. Biomedical engineering.

[24]  F. Zanella,et al.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.

[25]  Walter Stummer,et al.  Kinetics of Photofrin II in perifocal brain edema. , 1993, Neurosurgery.

[26]  A. Obwegeser,et al.  Photodynamic therapy in neurosurgery: a review. , 1996, Journal of photochemistry and photobiology. B, Biology.

[27]  A C Ruifrok,et al.  Growth characteristics of glioblastoma spheroids. , 2001, International journal of oncology.

[28]  H. Gabbert,et al.  Changes in O2 consumption of multicellular spheroids during development of necrosis. , 1985, Advances in experimental medicine and biology.

[29]  C. Brock,et al.  Current perspectives in gliomas , 1997, Medical oncology.

[30]  C. Mettlin,et al.  National survey of patterns of care for brain-tumor patients. , 1989, Journal of neurosurgery.

[31]  T. Foster,et al.  ALA- and ALA-hexylester-induced protoporphyrin IX fluorescence and distribution in multicell tumour spheroids , 2001, British Journal of Cancer.

[32]  C Dubessy,et al.  Spheroids in radiobiology and photodynamic therapy. , 2000, Critical reviews in oncology/hematology.

[33]  B. Tromberg,et al.  Development of a novel indwelling balloon applicator for optimizing light delivery in photodynamic therapy , 2001, Lasers in surgery and medicine.

[34]  J. Mosinger,et al.  Assessment of cellular damage by comet assay after photodynamic therapy in vitro. , 2004, Acta medica.

[35]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.

[36]  L. Juillerat-Jeanneret,et al.  5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells. , 2000, Journal of photochemistry and photobiology. B, Biology.

[37]  K. Wallner,et al.  Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. , 1989, International journal of radiation oncology, biology, physics.

[38]  Jun Chen,et al.  Programmed Cell Death in Cerebral Ischemia , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  A. Betz,et al.  Brain edema: a classification based on blood-brain barrier integrity. , 1989, Cerebrovascular and brain metabolism reviews.

[40]  H. Yung,et al.  Ischemia‐induced apoptosis in primary cultures of astrocytes , 2001, Glia.

[41]  T. Origitano,et al.  Photodynamic therapy for intracranial neoplasms , 1994, Molecular and chemical neuropathology.

[42]  G. B. V. Beijersbergen van Henegouwen,et al.  In Vitro Fluorescence, Toxicity and Phototoxicity Induced by δ-Aminolevulinic Acid (ALA) or ALA-Esters , 2000, Photochemistry and photobiology.

[43]  Vasilis Ntziachristos,et al.  Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. , 2003, Neoplasia.

[44]  W. Stummer,et al.  In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. , 1998, Journal of photochemistry and photobiology. B, Biology.

[45]  A. E. Saarnak,et al.  5-Aminolevulinic Acid Induced Endogenous Porphyrin Fluorescence in 9L and C6 Brain Tumours and in the Normal Rat Brain , 1998, Acta Neurochirurgica.

[46]  H Stepp,et al.  Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. , 2000, Journal of neurosurgery.